Oral gene therapy for hypoparathyroidism: A rat model

Human Gene Therapy

Volumn 20, Issue 11, 2009, Pages 1344-1350

  Chou, Fong Fu ^a   Huang, Shun Chen ^a   Chang, Shwu Fen ^b   Liaw, Jiahorng ^b   Hung, Pei Hua ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COMPLEMENTARY DNA; DRINKING WATER; EDETIC ACID; MACROGOL; MESSENGER RNA; PARATHYROID HORMONE[1-34]; PLASMID DNA; POLOXAMER; MACROGOL DERIVATIVE; MICELLE; PARATHYROID HORMONE; PEO-PPO-PEO; PRIMER DNA; PROPANEDIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CYTOMEGALOVIRUS; ESCHERICHIA COLI; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; GENE AMPLIFICATION; GENE THERAPY; HYPOPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; MALE; MICELLIZATION; MOUTH; NONHUMAN; PARATHYROIDECTOMY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; GENETICS; MICELLE; ORAL DRUG ADMINISTRATION; PLASMID; PROCEDURES; SPRAGUE DAWLEY RAT; THERAPEUTIC USE;

HUMAN HERPESVIRUS 5; RATTUS;

ADMINISTRATION, ORAL; ANIMALS; CALCIUM; CYTOMEGALOVIRUS; DNA PRIMERS; GENETIC THERAPY; HYPOPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; MALE; MICELLES; MODELS, ANIMAL; PARATHYROID HORMONE; PARATHYROIDECTOMY; PLASMIDS; POLYETHYLENE GLYCOLS; PROPYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70449105221     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.015     Document Type: Article

References (25)

1. Alakhov, V.Y., and Kabanov, A.V. (1998). Block copolymeric biotransport carriers as versatile vehicles for drug delivery expert opinion. Invest. Drugs 7, 1453-1473.
2. Alton, E.W., Middleton, P.G., Caplene, N.J., Smith, S.N., Steel, D.M., Munkonge, F.M., Jeffery, P.K., Geddes, D.M., Hart, S.L., Williamson, R., Fasold, K.I., Miller, A.D., Dickinson, P., Stevenson, B.J., McLachlan, G., Dorin, J.R., and Porteous, D.J. (1993). Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat. Genet. 5, 135-142.
3. Chang, S.F., Chang, H.Y., Tong, Y.C., Chen, S.H., Hsaio, F.C., Lu, S.C., and Liaw, J. (2004). Nonionic polymeric micelles for oral gene delivery in vivo. Hum. Gene Ther. 15, 481-493.
4. Forchillin, V.P. (2001). Structure and design of polymeric surfactant-bases drug delivery systems. J. Control. Release 73, 137-172.
5. Huang, M.J., Gou, M.L., Qian, Z.Y., Dai, M., Li, X.Y., Cao, M., Wang, K., Zhao, J., Yang, J.L., Lu, Y., Tu, M.J., and Wei, Y.Q. (2008). One-step preparation of poly(e-caprolactone)-poly(ethylene glycol)-poly(e-caprolactone) nanoparticles for plasmid DNA delivery. J. Biomed. Mater. Res. 86, 979-986.
6. Kabanov, A.V., Batrakova, E.V., and Alakhov, V.Y. (2002). Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release 82, 189-212.
7. Kwon, G.S., and Katota, K. (1995). Block copolymer micelles as long-circulating drug vehicles. Adv. Drug Deliv. Rev. 16, 295-309.
8. Kwon, G.S., and Okano, T. (1999). Soluble self-assembled block copolymers for drug delivery. Pharm. Res. 16, 597-600.
9. Kwon, G.S., Suwa, S., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K. (1994). Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide aspartate) block copolymer-Adriamycin conjugates. J. Control. Release 29, 17-23. (Pubitemid 24104093)
10. Liaw, J., and Lin, Y.C. (2000). Evaluation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) gels as a release vehicle for percutaneous fentanyl. J. Control. Release 68, 273-282.
11. Liaw, J., Chang, S.F., and Hsiao, F.C. (2001). In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) polymeric micelles. Gene Ther. 8, 999-1004.
12. Pepic, K., Jalsenjak, N., and Jalsenjak, I. (2004). Micellar solutions of triblock copolymer surfactants with pilocarpine. Int. J. Pharm. 272, 303-309.
13. Roque, C., Fatta, E., and Fromes, Y. (2009). Comparison of tox-icity and transfection efficiency of amphiphilic block copoly-mers and polycationic polymers in striated muscles. J. Gene Med. 11, 240-249.
14. Shoback, D. (2008). Hypoparathyroidism. N. Engl. J. Med. 359, 391-403.
15. Stolnik, S., Illam, L., and Davis, S.S. (1995). Long circulating micro particulate drug carriers. Adv. Drug Deliv. Rev. 16, 195-214.
16. Tal, A., and Powers, K. (1996). Milk-alkali syndrome induced by 1, 25(OH) 2D in a patient with hypoparathyroidism. J. Natl. Med. Assoc. 88, 313-314.
17. Thuret, G., Manissolle, C., Campos-Guyotat, L., Guyotat, D., and Gain, P. (2005). Animal compound-free medium and polox-amer for human corneal organ culture and deswelling. Invest. Ophthalmol. Vis. Sci. 46, 816-822.
18. Tong, Y.C., Chang, S.F., Liu, C.Y., Kao, W.W.Y., Huang, C.H., and Liaw, J. (2007). Eye drop delivery of nano-polymeric micelle formulated genes with cornea-specific promoters. J. Gene Med. 9, 956-966.
19. Wen, J.M., Zhong, Y.H., Sun, Y., Hung, Z., Zhang, L.W., Wu, QL., and Zeng, D.C. (2006). pcDPG parathyroid hormone gene therapy of hypoparathyroidism. Zhonghua Yi Xue Za Zhi 86, 260-265.
20. Winer, K.K., Yanovski, J.A., and Cutler, G.B., Jr. (1996). Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA 276, 631-636.
21. Winer, K.K., Ko, C.W., and Reynolds, J.C. (2003). Long-term treatment of hypoparathyroidism: A randomized control study comparing parathyroid hormone (1-34) versus calcitriol and calcium. J. Clin. Endocrinol. Metab. 880, 4241-14220.
22. Yokoyama, M. (1992). Block copolymers as drug carriers. Crit. Rev. Ther. Drug Carrier Syst. 9, 213-248.
23. Zhao, J., Gou, M.L., Dai, M., Li, X.Y., Cao, M., Huang, M.J., Wen, Y.J., Kan, B., Qian, Z.Y., and Wei, Y.Q. (2009). Preparation, characterization, and in vitro study of cationic PCL-Pluronic-PCL (PCFC) nanoparticles for gene delivery. J. Biomed. Mater. Res. A 90, 506-513.
24. Zhou, Y., Lu, B., Xu, P., and Song, C.F. (2005). Optimising gene therapy of hypoparathyroidism with hematopoietic stem cells. Chin. Med. J. 118, 204-209.
25. Zhu, Y.F., Ye, J.L., and Wang, S.M. (2006). pcKM-mPTH recom-binant plasmid therapy for hypoparathyroidism by poly-cationic liposome mediated transfection. Zhonghua Yi Xue Za Zhi 86, 837-840